Paravertebral Block for Breast Surgery

This study has been completed.
Sponsor:
Information provided by:
University of Aarhus
ClinicalTrials.gov Identifier:
NCT00131170
First received: August 15, 2005
Last updated: July 4, 2007
Last verified: July 2007
  Purpose

The effect of paravertebral block in combination with general anaesthesia is studied in a double blind fashion.


Condition Intervention Phase
Breast Cancer
Procedure: paravertebral block
Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double-Blind
Primary Purpose: Prevention

Resource links provided by NLM:


Further study details as provided by University of Aarhus:

Primary Outcome Measures:
  • Nausea and vomiting 2 hours postoperatively, and 1 and 2 days postoperatively [ Time Frame: 2 days ]

Secondary Outcome Measures:
  • Dosage of analgesic [ Time Frame: 1 day ]

Enrollment: 90
Study Start Date: September 2005
Study Completion Date: September 2006
Detailed Description:

Patients having surgery for breast cancer receive a paravertebral blockade at C8-Th4 with either Naropin 0.5% or saline. General anaesthesia is then provided with laryngeal mask intubation, propofol infusion and fentanyl i.v. as needed. The effect on postoperative pain ([VAS] and fentanyl PCA doses taken) and postoperative nausea and vomiting is recorded.

  Eligibility

Ages Eligible for Study:   18 Years to 85 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Breast surgery

Exclusion Criteria:

  • Infections
  • Coagulation disorder
  • Allergy
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00131170

Locations
Denmark
Dept of Anesthesiology, Aarhus University Hospital
Aarhus, Denmark, DK 8000
Sponsors and Collaborators
University of Aarhus
Investigators
Principal Investigator: Palle Carlsson, MD Dr Sci Dept anesthesiology, Arhus University Hospital
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00131170     History of Changes
Other Study ID Numbers: PVB1
Study First Received: August 15, 2005
Last Updated: July 4, 2007
Health Authority: Denmark: National Board of Health

Additional relevant MeSH terms:
Breast Neoplasms
Neoplasms by Site
Neoplasms
Breast Diseases
Skin Diseases

ClinicalTrials.gov processed this record on April 22, 2014